Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid
cancer. Since the guidelines for the management of ATC by the American Thyroid …

Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid
cancer. Rapid evaluation and establishment of treatment goals are imperative for optimum …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were …

PURPOSE: Anaplastic thyroid cancer (ATC) is a lethal disease causing a global
disproportionate number of thyroid cancer-related deaths. The American Thyroid …

Importance Anaplastic thyroid carcinoma (ATC) historically has a 4-month median overall
survival (OS) from time of diagnosis, with disease-specific mortality approaching 100%. The …

Context Historical outcomes in anaplastic thyroid cancer (ATC) have been dismal. Objective
To determine whether an initial intensive multimodal therapy (MMT) is associated with …

BACKGROUND Because anaplastic thyroid cancer is a rare malignancy with a high
mortality rate, the benefit of multimodality treatment was evaluated. METHODS Overall …

Anaplastic thyroid cancer (ATC) is an extremely aggressive but rare form of thyroid
malignancy, making up only 1% to 2% of all thyroid cancers. 1 Although the incidence of …

Background Anaplastic thyroid carcinoma (ATC) accounts for only 1 to 2% of all thyroid
carcinomas, but it is one of the most lethal neoplasms in humans. To date, most findings …

Anaplastic thyroid cancer (ATC) is an uncommon malignancy of the thyroid. Only 1‐2% of
thyroid cancers are anaplastic, but the disease contributes to 14–50% of the mortality with a …